Spots Global Cancer Trial Database for Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer
Official Title: Phase 1 Study of Stereotactic Hypofractionated Radiosurgery of Low Grade Prostate Cancer/Early Stage
Study ID: NCT00969202
Conditions
Interventions
Study Description
Brief Summary: The purpose of this trial is to evaluate a short course of very focused (stereotactic) external beam radiation therapy for the treatment of early stage prostate cancer. The investigators will gather scientific information about the tolerance and side effects this type of radiation. The investigators will then compare these results with those of standard 8 week course of external beam radiation therapy to see if this study treatment is equally or more effective in treating prostate cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
San Diego Radiosurgery at Palomar Medical Center, Escondido, California, United States
Contact Details
Name: P. Brian Volpp, MD, MPH
Affiliation: San Diego Radiosurgery/X-Ray Medical Group-Radiation Oncology
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
